Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of anti-TNF-alpha therapy on endothelial progenitor cells and endothelial dysfunction in psoriasis patients without atherosclerosis risk factors
2009-011397-14Phase 4Terminated
- Sponsor
- Technische Universität Dresden
- Start
- Aug 2009
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of etanercept in plaque psoriasis, sponsored by Technische Universität Dresden. Started Aug 2009; status: terminated.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2009-011397-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011397-14.